Gene Name |
protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched) |
transmembrane protein 51 |
Image |
|
No pdb structure |
Gene Ontology Annotations |
Cellular Component |
|
|
Molecular Function |
|
|
Biological Process |
|
|
Pathways |
|
|
Drugs |
|
|
Diseases |
|
|
GWAS |
- Adverse response to chemotherapy (neutropenia/leucopenia) (cisplatin) ( 23648065)
|
|
Protein-Protein Interactions |
11 interactors:
CUL5
CXCL9
FAM58A
FYN
MAPK1
MAPK3
SNX4
TERF1
TMEM51
VTI1B
ZBTB5
|
2 interactors:
MRPL12
PTPN5
|
Entrez ID |
84867 |
55092 |
HPRD ID |
01472 |
07651 |
Ensembl ID |
ENSG00000110786
|
ENSG00000171729
|
Uniprot IDs |
B7Z2F8
B7ZAF5
P54829
Q86TL3
|
Q9BSA0
Q9NW97
|
PDB IDs |
2BIJ
2BV5
2CJZ
|
|
Enriched GO Terms of Interacting Partners? |
|
|
Tagcloud ? |
ad
aggregated
aggregates
amyloid
beneficial
biology
burden
called
discovery
disrupts
economic
enriched
hyperphosphorylated
making
millions
modulating
neurofibrillary
neuropathology
nfts
plaques
representing
reviews
step
striatal
substantial
tangles
trafficking
turn
worldwide
|
|
Tagcloud (Difference) ? |
ad
aggregated
aggregates
amyloid
beneficial
biology
burden
called
discovery
disrupts
economic
enriched
hyperphosphorylated
making
millions
modulating
neurofibrillary
neuropathology
nfts
plaques
representing
reviews
step
striatal
substantial
tangles
trafficking
turn
worldwide
|
|
Tagcloud (Intersection) ? |
|